Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2019 Dec 3.
Published in final edited form as: Hastings Cent Rep. 2018 Jul;48(Suppl 2):S25–S27. doi: 10.1002/hast.880

A New Era, New Strategies: Education and Communication Strategies to Manage Greater Access to Genomic Information

Megan A Lewis 1, Natasha Bonhomme 2, Cinnamon S Bloss 3
PMCID: PMC6890375  NIHMSID: NIHMS1048572  PMID: 30133727

Genomic information is challenging to communicate. The results of genome sequencing can be numerous, uncertain, and ambiguous.1 The impact of many gene variants on a person’s health and future can be difficult to predict, especially when no symptoms have yet emerged, in part because these effects are moderated by numerous other factors, such as a person’s behaviors and environmental exposures over time. As next-generation genomic sequencing, including whole-genome sequencing information becomes more common in research, clinical, and public health contexts, there is a need for comprehensive communication strategies and education approaches to prepare patients and clinicians to manage this information and make informed decisions about its use. Nowhere is that imperative more pronounced than when genomic sequencing is applied to newborns.

Communicating a newborn’s sequencing information to their parents is fraught with challenges. For parents to process the information at an already busy time in their lives, it needs to be relevant, accessible, and actionable. Yet many genomic results may not meet these criteria, a fact that raises questions about the usefulness of such information for parents and calls for communication strategies that can deal with complexity and uncertainty. Most existing communication paradigms use an in-person genetic counseling approach. Interpersonal communication is an effective way to communicate complex information because it interpersonal communication changes in real-time to meet a parent’s specific needs.2 Unfortunately, because this approach takes time and requires special expertise, it is not scalable. There simply are not enough genetic counselors3, 4 or genetic counseling training programs to rely solely on one-to-one counseling sessions.

Even if more counselors can be trained, in-person counseling is unlikely to be applicable or cost-effective when genomic risk information is obtained by parents directly via the internet.5 As a general rule, communication strategies should match how people are accessing health information. In the past, people obtained health information in clinical settings, which at least in theory, created the opportunity for in-person counseling. Today, however, many people can obtain health information in a variety of settings, including over the Internet and through direct-to-consumer services, via websites, and through other digital channels or settings. In response to these changes, new communication strategies need to be considered. Adopting a comprehensive communication model means understanding the multiple levels of influence experienced by parents and the clinicians who serve them.6 In addition, applying communication science principles can help address some key challenges to effectively communicating genomic information to parents.7

At the level of the individual, it is important to recognize that while parents in the United States vary in their beliefs, values, and knowledge about genomics, health literacy and genomic literacy are generally quite low, which limits parents’ ability to understand the benefits, risks, and overarching ramifications of their child’s genomic information.8 One way to begin addressing these literacy issues is to ensure that the information is presented in plain language that lay people understand. Research shows that when information is made more accessible, by using plain language and applying clear communication principles, it is more effective and actionable for recipients.9 Communicators should seek to identify and prioritize parental needs, including putting the most important information first, using common words, explaining technical terms, using bullets or lists, summarizing information, and using short sentences. These all represent easy, evidence-based approaches that can be implemented in digital, written, or verbal communication. Additionally, using best practices for conveying risk information—such as risk arrays and using smaller denominators (e.g., 100 vs 10,000)—and using multiple and graphical formats can help make complex information more easily understandable and accessible.10 Easily understandable information can be disseminated through a variety of channels online or via paper-based methods. Information design makes the information more accessible, but does not address low population genomic literacy, which can only be enhanced by significant, long-term investments in national and community educational campaigns. These educational campaigns could be launched by state and federal agencies or large health systems or insurers.

At the interpersonal level, an important challenge is the potential need for parents to work collaboratively with each other and with clinicians to make informed and shared decisions about whether and how to act on their newborn’s sequencing results. One evidence-based method to facilitate collaborative decisions is the use of decision aids,11, 12 particularly if they are delivered digitally. Typically, decision aids include values clarification exercises that help parents understand what is important to them when making a decision about sequencing information and can help prepare them for clinical encounters. Emerging research suggests that decision aids can be particularly effective for supporting informed decision making among parents with lower health literacy.13 Decision aids could be implemented in visits women make to clinical providers during pregnancy to prepare them for newborn screening decisions.

At the organizational level, family physicians, pediatricians, and other clinicians working in health care systems that serve pregnant women and new mothers, are currently under-prepared to support the additional complexity that sequencing may bring to the newborn period. Focused clinician education in genomic medicine needs to start in premedical education and continue through ongoing professional and specialty training for practicing clinicians.14 In addition, healthcare organizations need to find ways to support clinicians in deciding how and when to communicate with parents about sequencing. Thus far, these initiatives have included clinical decision support tools that are typically embedded in the electronic health record and intended to guide providers as they discuss results and next steps.15 Such systems require complex informatics and input from multiple stakeholders to be useful in clinical care.16 How they can be implemented effectively in genomic studies, particularly in the pediatrics field, is an active area of research17 and should include studies to determine their utility.

At a community level, the many settings parents visit in their pregnancy journey could be used to disseminate information and potentially gather input. While communication strategies that can be used in clinical contexts are important, parents are likely to learn about and discuss newborn sequencing in other settings as well. Communication science principles call for “meeting people where they are” by understanding where and how they seek information, what types of communication channels they use, and what sources parents view as trustworthy. Today, these channels invariably include the internet, social media, and other information accessible via mobile devices, none of which have yet been adequately integrated into efforts to communicate sequencing results. Doing so could support and prepare parents for encounters in clinical contexts and address any questions that may emerge afterward.

Finally, at the policy level, we note that the absence of protections for parents and their newborns has the potential to limit the type of information parents would want to receive or make the information less actionable once they do receive it. Parents have valid concerns about the possible acquisition and storage of genome sequencing data by state newborn screening programs and about the inclusion of sequencing information in their child’s medical record.1820 These concerns could deter parents from accepting offers of sequencing, thereby stymieing research and practice in this area. Policy changes are needed to protect families who need or desire to learn genomic information from privacy violations and discrimination.

Communication research focusing on how genomic information should be communicated to parents of newborns is in its infancy. More resources must be devoted to this research area to help fill the large translational gap in this area. Most research funds often go to basic science discovery versus to solving translational issues.21 This has left the parents and the clinicians who serve them without access to the tools, knowledge, and resources to collaboratively make preference-sensitive, family-centric decisions about a newborn’s genomic information.22, 23 To assist families, healthcare providers, companies and others tasked with communicating sequencing information we must apply evidence-based communication science practices and work to develop new tools that can effectively and efficiently communicate sometimes complex and uncertain genomic information. Application of these practices and development of new tools will help alleviate some of the ethical concerns related to providing sequencing information. We also recommend that education about genomics be incorporated in settings that already provide education to clinicians and parents. In addition, larger scale awareness and educational campaigns need to be developed, implemented and evaluated to address low genetic literacy levels in the community as a whole. Advancing the field of genomics means advancing both education and communication strategies to fill the large translational gap in this area.

References

  • 1.Han PKJ, Umstead KL, Bernhardt BA, et al. A taxonomy of medical uncertainties in clinical genome sequencing. Genet Med. 2017. August;19(8):918–25. doi: 10.1038/gim.2016.212. PMID: . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Lewis MA, DeVellis B, Sleath B. Interpersonal communication and social influence In: Glanz K, Lewis FM, Rimer BK, eds. Health behavior and health education: Theory, research, and practice. 3rd ed San Francisco: Jossey-Bass; 2002:363–402. [Google Scholar]
  • 3.Rosenthal ET. Shortage of genetics counselors may be anecdotal, but need is real. Oncology Times. 2007;29(19):34. doi: 10.1097/01.cot.0000297237.14764.14. [DOI] [Google Scholar]
  • 4.Cohen SA, Tucker ME, Delk P. Genetic counselor workforce issues: a survey of genetic counselors licensed in the state of Indiana. J Genet Couns. 2017. June;26(3):567–75. doi: 10.1007/s10897-016-0026-y. PMID: . [DOI] [PubMed] [Google Scholar]
  • 5.Bloss CS, Darst BF, Topol EJ, et al. Direct-to-consumer personalized genomic testing. Hum Mol Genet. 2011. October 15;20(R2):R132–41. doi: 10.1093/hmg/ddr349. PMID: . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Establishing Stokols D. and maintaining healthy environments: Toward a social ecology of health promotion. Am Psychol. 1992;47(1):6–22. doi: 10.1037/0003-066x.47.1.6. [DOI] [PubMed] [Google Scholar]
  • 7.Squiers L, Peinado S, Berkman N, et al. The health literacy skills framework. J Health Commun. 2012;17(Suppl 3):30–54. doi: 10.1080/10810730.2012.713442. PMID: . [DOI] [PubMed] [Google Scholar]
  • 8.Hurle B, Citrin T, Jenkins JF, et al. What does it mean to be genomically literate?: National Human Genome Research Institute Meeting Report. Genet Med. 2013. August;15(8):658–63. doi: 10.1038/gim.2013.14. PMID: . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.McCormack L, Sheridan S, Lewis M, et al. Communication and Dissemination Strategies To Facilitate the Use of Health-Related Evidence Evidence Report/Technology Assessment No. 213 (Prepared by the RTI International–University of North Carolina Evidence-based Practice Center under Contract No. 290–2007-10056-I.). AHRQ Publication No. 13(14)-E003-EF. Rockville, MD: Agency for Healthcare Research and Quality; November 2013. [Google Scholar]
  • 10.Lautenbach DM, Christensen KD, Sparks JA, et al. Communicating genetic risk information for common disorders in the era of genomic medicine. Annu Rev Genomics Hum Genet. 2013;14:491–513. doi: 10.1146/annurev-genom-092010-110722. PMID: . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Legare F, Robitaille H, Gane C, et al. Improving decision making about genetic testing in the clinic: an overview of effective knoedge translation interventions. PLOS ONE. 2016;11(3):e0150123. doi: 10.1371/journal.pone.0150123. PMID: . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Lewis MA, Paquin RS, Roche MI, et al. Supporting parental decisions about genomic sequencing for newborn screening: The NC NEXUS decision aid. Pediatrics. 2016. January;137 Suppl 1:S16–23. doi: 10.1542/peds.2015-3731E. PMID: . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Peinado S, Paquin RS, Lewis MA, et al. Values clarification exercises improved parental decision making about newborn genomic sequencing. Abstract submitted to the 2018 annual meeting and scientific sessions of the Society of Behavioral Medicine; under review New Orleans, LA. [Google Scholar]
  • 14.Korf BR. Genomic medicine: educational challenges. Mol Genet Genomic Med. 2013. September;1(3):119–22. doi: 10.1002/mgg3.38. PMID: . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Overby CL, Kohane I, Kannry JL, et al. Opportunities for genomic clinical decision support interventions. Genet Med. 2013. October;15(10):817–23. doi: 10.1038/gim.2013.128. PMID: . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Brinner KA, Downing GJ. Advancing patient-centered pediatric care through health information exchange: Update from the American Health Information Community Personalized Health Care Workgroup. Pediatrics. 2009. January;123(S2):S122–S4. doi: 10.1542/peds.2008-1755N. PMID: . [DOI] [PubMed] [Google Scholar]
  • 17.Gottesman O, Kuivaniemi H, Tromp G, et al. The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future. Genet Med. 2013. October;15(10):761–71. doi: 10.1038/gim.2013.72. PMID: . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Joseph G, Chen F, Harris-Wai J, et al. Parental views on expanded newborn screening using whole-genome sequencing. Pediatrics. 2016. January;137(s1):S36–S46. doi: 10.1542/peds.2015-3731H. PMID: . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Clayton EW. Ethical, legal, and social implications of genomic medicine. N Engl J Med. 2003. August 07;349(6):562–9. doi: 10.1056/NEJMra012577. PMID: . [DOI] [PubMed] [Google Scholar]
  • 20.Friedman JM, Cornel MC, Goldenberg AJ, et al. Genomic newborn screening: public health policy considerations and recommendations. BMC Med Genomics. 2017. February 21;10(1):9. doi: 10.1186/s12920-017-0247-4. PMID: . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.McBride CM, Abrams LR, Koehly LM. Using a historical lens to envision the next generation of genomic translation research. Public Health Genomics. 2015;18(5):272–82. doi: 10.1159/000435832. PMID: . [DOI] [PubMed] [Google Scholar]
  • 22.Bailey DB Jr., Armstrong FD, Kemper AR, et al. Supporting family adaptation to presymptomatic and “untreatable” conditions in an era of expanded newborn screening. J Pediatr Psychol. 2009. July;34(6):648–61. doi: 10.1093/jpepsy/jsn032. PMID: . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Nicholls SG, Wilson BJ, Etchegary H, et al. Benefits and burdens of newborn screening: public understanding and decision-making. Per Med. 2014;11(6):593–607. doi: 10.2217/Pme.14.46. PMID: . [DOI] [PubMed] [Google Scholar]

RESOURCES